| Name | Deuruxolitinib |
|---|
| Description | Deuruxolitinib (CTP-543), a deuterated Ruxolitinib, modulates the activity of JAK1/JAK2. Deuruxolitinib can be used for the research hair loss disorders (from patent WO2017192905A1, compound I)[1]. |
|---|---|
| Related Catalog | |
| Target |
JAK1 JAK2 |
| References |
| Molecular Formula | C17H10D8N6 |
|---|---|
| Molecular Weight | 314.41 |